CLXRX Financial Statements & Analysis
Complete financial statements for CLXRX including income statement, balance sheet, and cash flow statement. Analyze CLXRX's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
-13.4% ↓
Net Income
620.2% ↑
Gross Margin
74.7% ↑
Operating Margin
231.8% ↑
Balance Sheet
Current Ratio
-18.2% ↓
Debt to Equity
0.1% ↓
Asset Turnover
-10.8% ↓
Cash Flow
Operating Cash Flow
85.1% ↑
Net Cash Flow
123.6% ↑
Free Cash Flow
536.1% ↑
Cash Flow to Debt
90.3% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2022 | 2023 | Change | Impact |
|---|---|---|---|---|
| Revenue | 100.66B | 87.17B | 13.4% | |
| Gross Profit | 18.86B | 28.53B | 51.3% | |
| Operating Income | 5.28B | 15.18B | 187.4% | |
| Net Income | 924.00M | 6.66B | 620.2% | |
| EPS | 0.37 | 2.63 | 610.8% | |
| EBITDA | 13.84B | 23.40B | 69.1% | |
| Gross Margin | 18.73% | 32.73% | 74.7% | |
| Operating Margin | 5.25% | 17.42% | 231.8% | |
| Net Income Margin | 0.92% | 7.63% | 731.7% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 87.17B | 100.66B | 83.96B | — | — |
| Gross Profit | 28.53B | 18.86B | 26.63B | — | — |
| Operating Income | 15.18B | 5.28B | 12.21B | — | — |
| Net Income | 6.66B | 924.00M | 8.49B | — | — |
| EPS | 2.63 | 0.37 | 3.36 | — | — |
| EBITDA | 23.40B | 13.84B | 21.18B | — | — |
| Gross Margin | 32.73% | 18.73% | 31.71% | — | — |
| Operating Margin | 17.42% | 5.25% | 14.54% | — | — |
| Net Income Margin | 7.63% | 0.92% | 10.11% | — | — |
| R&D Expenses | 0 | 0 | 0 | — | — |
Financial Metrics
Want to dive deeper into CLXRX's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics